Pccr Usa, Inc. history

Then, through the expansion of the plant in 1986, the phthalic anhydride and special plasticisers productions were started directly on site.

1989 Walther Cancer Institute scientific partnership begins

In the meantime, the Company acquires Reglar S.r.l., active in the sector of composite materials molding (1991).

From 1999, the Ravenna site also starts production of tetrahydrophthalic anhydride, a derivative of maleic anhydride.

In 2001, Polynt acquires the German companies Lonza Compounds Verwaltungs and Lonza Compounds, based in Miehlen; the latter specialized in the production of composite materials molding based on unsaturated polyester resin.

2004 Partnership launched with IU Simon Cancer Center

In 2005, as part of a strategy to expand into the emerging Eastern European markets, the Company sets up Lonza Poland Sp.

On 1st August 2006, Lonza S.p.A. changes its name to Polynt S.p.A.. On 30 October 2006, Polynt is listed on the STAR segment of the Italian Stock Exchange.

2007 Timothy Ratliff becomes PCCR director

In April 2008, following the takeover bid, Polynt S.p.A. is acquired by Polimeri Speciali S.P.A. (indirectly controlled by Invest Industrial) and delisted from the Italian Stock Exchange.

On 1st January 2012, Polynt France SARL becomes operational and has managed the marketing and sale of the Group’s products on the French market from its office in Lyon since 1st April 2012.

2018 Tyler Trent becomes first student on Advancement Board